Limited Period Offer:Be a PRO for 1 month @Rs49/-Multiple payment options available. Know More

Coronavirus update: Single-day cases breach one-lakh mark for second time in three days

Coronavirus update:

April 07, 2021 / 10:18 AM IST
Coronavirus

Coronavirus

The number of new coronavirus cases in India hit a record daily high since the outbreak of the pandemic with over 1.15 lakh new infections being reported in a span of 24 hours, pushing the nationwide COVID-19 tally to 1,28,01,785, according to the Union Health Ministry data updated on Wednesday.

The single-day rise in coronavirus cases breached the 1-lakh mark for the second time in three days. A total of 1,15,736 infections were reported in a day, while the death toll increased to 1,66,177 with 630 daily new fatalities, the data updated at 8 am showed.

Registering a steady increase for the 28th day in row, the active cases have increased to 8,43,473 comprising 6.59 percent of the total infections, while the recovery rate has further dropped to 92.11 percent, the data stated.

The active caseload was at its lowest at 1, 35,926 on February 12 comprising 1.25 percent of the total infections.

The number of people who have recuperated from the disease surged to 1,17,92,135, while the case fatality rate has further dropped to 1.30 percent, the data stated.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

India's COVID-19 tally had crossed the 20-lakh mark on August 7,30 lakh on August 23, 40 lakh on September 5 and 50 lakh on September 16. It went past 60 lakh on September 28, 70 lakh on October 11, crossed 80 lakh on October 29, 90 lakh on November 20 and surpassed the one-crore mark on December 19.

According to the ICMR, 25,14, 39,598 samples have been tested up to April 6 with 12,08, 339 samples being tested on Tuesday.

(With PTI inputs)
Moneycontrol News
first published: Apr 7, 2021 10:11 am

stay updated

Get Daily News on your Browser
Sections